The Long Shot: The Inside Story of the Race to Vaccinate Britain

£18.99

On 3 April 2020, Kate Bingham was told that the likelihood of any COVID-19 vaccine working was 15% at best. But on 8 December 2020, the first NHS patient received a vaccine. Now nearly every adult in Britain has had a jab, lockdowns have ended and we can finally live with Covid. What lies behind this staggering success story? From a small cottage, Bingham juggled vaccine suppliers, Whitehall, the media circus – and her daughter’s exams. Political manoeuvring, miscommunications and administrative meddling nearly jeopardised the project. But perseverance paid off. Catapulted into a national crisis, Bingham’s eclectic team secured the first vaccine doses administered in the West and saved thousands of lives in the UK as new variants struck. This is an insider view into how the Vaccine Taskforce beat the odds and delivered the scientific miracle we all waited for.

ISBN: 9780861545643 Author: Bingham, Kate Publisher: Oneworld Publications Publication Date: 20th October 2022 Imprint: Oneworld Cover: Hardback Dewey: 615.372 (edition:23) Pages: 352 Language: English Readership: General - Trade / Code: K Category: Subjects: , , ,

The Sunday Times bestseller

FT Book of the Year

On 3 April 2020, Kate Bingham was told that the likelihood of any Covid-19 vaccine working was 15% at best. But on 8 December 2020, the first NHS patient received a vaccine. Now nearly every adult in Britain has had a jab, lockdowns have ended and we can finally live with Covid. What lies behind this staggering success story?

From a cottage miles away from Westminster, Bingham juggled vaccine suppliers, Whitehall, the media circus – and her daughter’s exams. Political manoeuvring, miscommunications and administrative meddling nearly jeopardised the project. But perseverance paid off.

Catapulted into a national crisis, Bingham’s eclectic team secured the first vaccine doses administered in the West and saved thousands of lives in the UK as new variants struck. This is an unmissable insider view into how the Vaccine Taskforce beat the odds and delivered the scientific miracle we all waited for.

In stock